Schroder Investment Management Group
ACOR

Schroder Investment Management Group’s Acorda Therapeutics ACOR Stock Holding History

Schroder Investment Management Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,262
Closed -$3.61M – 1257
2019
Q1 		$3.61M Sell
2,262
-95
-4% -$171K 0.01% 736
2018
Q4 		$4.41K Buy
2,357
+2,310
+4,915% +$5.03M 0.01% 691
2018
Q3 		$112K Buy
+47
New +$145K ﹤0.01% 1170
2014
Q2 		– Sell
-19
Closed -$87.3K – 1459
2014
Q1 		$87.3K Hold
19
– – ﹤0.01% 1237
2013
Q4 		$67.2K Buy
19
+17
+850% +$66.3K ﹤0.01% 1323
2013
Q3 		$6.91K Buy
+2
New +$8.62K ﹤0.01% 1473

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Schroder Investment Management Group's ACOR Position: Q2 2019 in Review

Schroder Investment Management Group sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 2,262 shares — an estimated $3.61M sold.

Schroder Investment Management Group first reported a position in ACOR in Q3 2013 and held it in 6 quarters. The position peaked at $3.61M in Q1 2019. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • Schroder Investment Management Group reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Schroder Investment Management Group sold 2,262 Acorda Therapeutics shares in Q2 2019, an estimated $3.61M.
  • Schroder Investment Management Group first reported a position in Acorda Therapeutics in Q3 2013 and held it in 6 quarters.
  • Schroder Investment Management Group's Acorda Therapeutics position peaked at $3.61M in Q1 2019.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Schroder Investment Management Group's 13F filing for Q2 2019, filed 8 Aug 2019.